From Molecule To Milestone: Fast Track Formulation

From molecule to milestone, speed only matters if it is built on the right strategy. In this episode of the AustinPx Live Series, we explore how fast-track formulation approaches can accelerate programs toward First-in-Human studies without compromising long-term manufacturability. Our team walks through phase-appropriate formulation screening, early bioavailability assessment, and integrated CMC planning designed to align technical decisions with clinical and commercial goals. By combining rapid prototyping with a clear understanding of scale-up requirements, we help sponsors avoid costly pivots later in development. Whether the objective is speed to clinic or optimization of bioavailability, this session highlights how structured, data-driven formulation pathways can reduce risk, control timelines, and strengthen asset value from the start. Built with the end in mind, our approach ensures that progress toward early milestones also supports future scalability and performance. Where complex challenges meet tailored solutions. Learn more at www.austinpx.com.